SELECTED FINANCIAL STATEMENT INFORMATION (Tables)

3 Months Ended

Jan. 31, 2016

Selected Financial Statement Information [Abstract]

Schedule of Accounts Receivable [Table Text Block]

Accounts Receivable

(in thousands)	January 31, 2016			October 31, 2015
Accounts receivable		$177,065			$183,631
Less: Allowance for doubtful accounts	(3,150		)	(2,038		)
Accounts receivable, net		$173,915			$181,593

Schedule of Costs in Excess of Billings and Billings in Excess of Costs [Table Text Block]

Costs and Estimated Earnings on Uncompleted Percentage-of-Completion Contracts

(in thousands)	January 31, 2016			October 31, 2015
Costs incurred on uncompleted contracts		$24,387			$22,645
Estimated earnings	18,247			16,116
	42,634			38,761
Less: Billings to date	(36,119		)	(36,442		)
		$6,515			$2,319
Included in the accompanying Condensed Consolidated Balance Sheets under the following captions:
Accounts receivable, net (costs and estimated earnings in excess of billings)		$11,437			$6,263
Accrued expenses and other current liabilities (billings in excess of costs and estimated earnings)	(4,922		)	(3,944		)
		$6,515			$2,319

Schedule of Inventories [Table Text Block]

Inventories

(in thousands)	January 31, 2016			October 31, 2015
Finished products		$122,442			$119,262
Work in process	35,459			32,201
Materials, parts, assemblies and supplies	113,576			89,739
Contracts in process	3,744			4,521
Less: Billings to date	(1,727		)	(2,206		)
Inventories, net of valuation reserves		$273,494			$243,517

Schedule of Property, Plant and Equipment [Table Text Block]

Property, Plant and Equipment

(in thousands)	January 31, 2016			October 31, 2015
Land		$4,586			$5,060
Buildings and improvements	72,261			70,626
Machinery, equipment and tooling	161,601			152,022
Construction in progress	5,915			4,668
	244,363			232,376
Less: Accumulated depreciation and amortization	(131,677		)	(126,706		)
Property, plant and equipment, net		$112,686			$105,670

Schedule of Research and Development Expenses [Table Text Block]

The amount of new product research and development ("R&D") expenses included in cost of sales for the three months ended January 31, 2016 and 2015 is as follows (in thousands):

	Three months ended January 31,
	2016		2015
R&D expenses		$9,007		$9,302

Schedule of Redeemable Noncontrolling Interests [Table Text Block]

Management's estimate of the aggregate Redemption Amount of all Put Rights that the Company could be required to pay is as follows (in thousands):

	January 31, 2016		October 31, 2015
Redeemable at fair value		$76,783		$76,929
Redeemable based on a multiple of future earnings	14,353		14,353
Redeemable noncontrolling interests		$91,136		$91,282

Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]

Changes in the components of accumulated other comprehensive loss for the three months ended January 31, 2016 are as follows (in thousands):

	Foreign Currency Translation			Pension Benefit Obligation			Accumulated Other Comprehensive Loss
Balances as of October 31, 2015		($24,368	)		($712	)		($25,080	)
Unrealized loss	(2,463		)	—			(2,463		)
Balances as of January 31, 2016		($26,831	)		($712	)		($27,543	)